Name Manager
Subject Combinable therapy system with AGF39?_Chapter 3
Date 2024-06-11
Q. Combinable therapy system with AGF39? – Chapter 3

The AGF39 Hair Care Program recommends an optimal approach to secure clear scientific and clinical validation regarding the effectiveness of hair loss treatments, ensuring rapid experiences and sustained results.
To achieve this, a synthetic combination therapy involving AGF39 may be suggested.

 PRP(Platelet-Rich Plasma)
Blood contains nearly all the nutrients needed for the survival and growth of biological tissues. Platelets, in particular, play a crucial role in wound healing and regeneration by containing fibrin and various growth factor cytokines. The practice of concentrating platelets from blood for medical treatments originated in dentistry. Since the oral mucosa is less conducive to hemostasis and tissue regeneration following invasive procedures compared to other areas, dentists were likely the first to utilize Platelet-Rich Plasma (PRP) therapy.
Next, dermatology took an interest in the effects of PRP. Dermatologists focus on the growth factor cytokines in PRP, which are crucial for promoting skin tissue regeneration and are therefore important in anti-aging treatments. Similarly, these growth factors can be highly beneficial for treating hair loss. However, one drawback of PRP treatment is the inconvenience of needing to collect between 20cc and 50cc of blood from the patient during each visit.
Another drawback is that only a small amount of the growth factor cytokines in PRP are extracted. Even with the most advanced and expensive PRP kits, most growth factors are extracted in units of pg/ml, which is only 1/10,000 of AGF39. TGF-β, the most abundantly extracted growth factor at 137 µg/ml, also acts as a cell apoptotic factor in hair.
 Despite these limitations, the fresh and diverse high-quality proteins present in PRP can provide robust vitality to regressed hair follicles. In the AGF39 hair loss treatment program, simultaneous PRP treatment during the initial session can significantly complement the effects of AGF39. While AGF39 works to normalize the hair growth mechanism, PRP can serve as a temporary booster, enhancing the overall efficacy of the treatment.
 Unfortunately, Platelet-Poor Plasma (PPP), discarded during the PRP refining process, is a crucial nutrient for regenerating degenerated hair follicles, yet its significance tends to be overlooked. By incorporating PPP into treatments, the need for blood collection can be minimized. Therefore, it is advisable for experts who believe in the effectiveness of AGF39 to consider AesMed's proposal.